See background of NCD 32985.
See background of NCD 32984 for overall technology description.
This technology includes methods and placeholder peptides for the creation of peptide receptive HLA-A*68:02 and HLA-A*24:02 using TAPBPR in bacteria.
Peptide receptive MHC-I multimers of HLA-A*68:02 and HLA-A*24:02
Identification of peptide epitopes of HLA-A*68:02 and HLA-A*24:02
Specific placeholder peptides for the production of peptide receptive HLA-A*68:02 and HLA-A*24:02
Country | Type | Number | Dated | Case |
European Patent Office | Published Application | EP 4 136 098 | 02/22/2023 | 2020-284 |
United States Of America | Published Application | 20210371499 | 12/20/2021 | 2020-284 |
HLA-A*68:02, HLA-A*24:02, peptide receptive MHC-I